Skip to content

Biased µ-opioid receptor agonist tegileridine for postoperative analgesia after gynecologic laparoscopy or abdominal surgery: a prospective, double-blind, randomized controlled trial

Biased µ-opioid receptor agonist tegileridine for postoperative analgesia after gynecologic laparoscopy or abdominal surgery: a prospective, double-blind, randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122652
Enrollment
Unknown
Registered
2026-04-16
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative analgesia after gynecologic laparoscopy or abdominal surgery

Interventions

Experimental group:PCIA regimen The PCIA pump was set as follows: tegileridine 3 mg, flurbiprofen axetil 100 mg, ondansetron 8 mg, dexamethasone 5 mg, and haloperidol 1 mg were diluted to a total volu
Control group:PCIA regimen The PCIA pump was prepared as follows: sufentanil 30 µg, nalbuphine 20 mg, ketorolac tromethamine 60 mg, ondansetron 8 mg, dexamethasone 5 mg, and haloperidol 1 mg were dilu

Sponsors

Maternal and Child Health Hospital of Jiangxi Province
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Female patients aged 18–65 years, with ASA physical status I–III, scheduled for elective gynecological laparoscopic or open surgery, and who had provided written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients undergoing myomectomy or adenomyomectomy; 2. Hypersensitivity to the study drugs; 3. Long-term use of opioids (>1 week); 4. Severe hepatic or renal dysfunction, chronic intestinal obstruction, or inflammatory bowel disease; 5. Uncorrected nausea, vomiting, or severe constipation before surgery; 6. Use of antiemetics or prokinetic agents within 24 hours preoperatively; 7. History of opioid or alcohol abuse; 8. Mental or cognitive disorders that prevent cooperation with assessment

Design outcomes

Primary

MeasureTime frame
Time to first flatus;

Secondary

MeasureTime frame
Incidence of nausea, vomiting, and dizziness within 24–48 hours postoperatively.;Numerical Rating Scale (NRS) scores at rest and during activity at 24?h and 48?h postoperatively.;The number of effective PCIA compressions, total analgesic solution consumption, and the number of cases requiring rescue analgesia within 24 h and 48 h postoperatively were recorded.;

Countries

China

Contacts

Public ContactLi Huanhuan

Jiangxi Maternal and Child Health Hospital

446019174@qq.com+86 159 7904 8151

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026